Republican Gov. Jeff Landry, if he considers costs and outcomes, has good reason to veto SB 433.
The bill by Democrat state Sen. Gerald Boudreaux, after a few iterations, would have the state cover for Medicaid weight loss drugs for obesity, as prescribed. Louisiana Medicaid already covers it for clients where weight gain is a consequence of a chronic condition, which this expansion would not require. This has a five-year estimated cost of $72 million.
Here, the thinking is that obesity causes other maladies that eventually could fall under Medicaid treatment, hence needing state taxpayer support (although Louisiana typically has between 60-70 percent of costs covered by the federal government, so the bill has the Department of Health promulgate standards that would be consistent with federal regulations). By preventing obesity, the guess is that the use of semaglutide, the chemical in the drugs practically speaking that would have to be prescribed, would cost less than the eventual cost of treatment for other preventable conditions.